메뉴 건너뛰기




Volumn 5, Issue FEB, 2017, Pages

Strategies to inhibit Myc and their clinical applicability

Author keywords

Clinical application; Inhibitor; Myc; Omomyc; Oncogene; Therapy

Indexed keywords


EID: 85026824000     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2017.00010     Document Type: Review
Times cited : (239)

References (154)
  • 1
    • 84989325811 scopus 로고    scopus 로고
    • BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects
    • Abedin, S. M., Boddy, C. S., and Munshi, H. G. (2016). BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects. Onco. Targets Ther. 9, 5943-5953. doi: 10.2147/OTT.S100515
    • (2016) Onco. Targets Ther , vol.9 , pp. 5943-5953
    • Abedin, S.M.1    Boddy, C.S.2    Munshi, H.G.3
  • 2
    • 84946014028 scopus 로고    scopus 로고
    • BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
    • Ambrosini, G., Sawle, A. D., Musi, E., and Schwartz, G. K. (2015). BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells. Oncotarget 6, 33397-33409. doi: 10.18632/oncotarget.5179
    • (2015) Oncotarget , vol.6 , pp. 33397-33409
    • Ambrosini, G.1    Sawle, A.D.2    Musi, E.3    Schwartz, G.K.4
  • 3
    • 84992314131 scopus 로고    scopus 로고
    • Clinical trials for BET inhibitors run ahead of the science
    • Andrieu, G., Belkina, A. C., and Denis, G. V. (2016). Clinical trials for BET inhibitors run ahead of the science. Drug Discov. Today Technol. 19, 45-50. doi: 10.1016/j.ddtec.2016.06.004
    • (2016) Drug Discov. Today Technol , vol.19 , pp. 45-50
    • Andrieu, G.1    Belkina, A.C.2    Denis, G.V.3
  • 4
    • 84933586864 scopus 로고    scopus 로고
    • Talimogene laherparepvec improves durable response rate in patients with advanced melanoma
    • Andtbacka, R. H., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., et al. (2015). Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33, 2780-2788. doi: 10.1200/JCO.2014.58.3377
    • (2015) J. Clin. Oncol , vol.33 , pp. 2780-2788
    • Andtbacka, R.H.1    Kaufman, H.L.2    Collichio, F.3    Amatruda, T.4    Senzer, N.5    Chesney, J.6
  • 5
    • 84907303705 scopus 로고    scopus 로고
    • Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis
    • Annibali, D., Whitfield, J. R., Favuzzi, E., Jauset, T., Serrano, E., Cuartas, I., et al. (2014). Myc inhibition is effective against glioma and reveals a role for Myc in proficient mitosis. Nat. Commun. 5:4632. doi: 10.1038/ncomms5632
    • (2014) Nat. Commun , vol.5 , pp. 4632
    • Annibali, D.1    Whitfield, J.R.2    Favuzzi, E.3    Jauset, T.4    Serrano, E.5    Cuartas, I.6
  • 6
    • 0034008290 scopus 로고    scopus 로고
    • c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity
    • Arora, V., Knapp, D. C., Smith, B. L., Statdfield, M. L., Stein, D. A., Reddy, M. T., et al. (2000). c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity. J. Pharmacol. Exp. Ther. 292, 921-928
    • (2000) J. Pharmacol. Exp. Ther , vol.292 , pp. 921-928
    • Arora, V.1    Knapp, D.C.2    Smith, B.L.3    Statdfield, M.L.4    Stein, D.A.5    Reddy, M.T.6
  • 7
    • 0037133575 scopus 로고    scopus 로고
    • Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts
    • Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C., Maslyar, D. J., Goldberg, J., et al. (2002). Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 99, 3830-3835. doi: 10.1073/pnas.062036999
    • (2002) Proc. Natl. Acad. Sci. U.S.A , vol.99 , pp. 3830-3835
    • Berg, T.1    Cohen, S.B.2    Desharnais, J.3    Sonderegger, C.4    Maslyar, D.J.5    Goldberg, J.6
  • 8
    • 84962523963 scopus 로고    scopus 로고
    • Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
    • Berthon, C., Raffoux, E., Thomas, X., Vey, N., Gomez-Roca, C., Yee, K., et al. (2016). Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study. Lancet Haematol. 3, e186-e195. doi: 10.1016/S2352-3026(15)00247-1
    • (2016) Lancet Haematol , vol.3 , pp. e186-e195
    • Berthon, C.1    Raffoux, E.2    Thomas, X.3    Vey, N.4    Gomez-Roca, C.5    Yee, K.6
  • 9
    • 84971434949 scopus 로고    scopus 로고
    • The bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma
    • Bid, H. K., Phelps, D. A., Xaio, L., Guttridge, D. C., Lin, J., London, C., et al. (2016). The bromodomain BET inhibitor JQ1 suppresses tumor angiogenesis in models of childhood sarcoma. Mol. Cancer Ther. 15, 1018-1028. doi: 10.1158/1535-7163.MCT-15-0567
    • (2016) Mol. Cancer Ther , vol.15 , pp. 1018-1028
    • Bid, H.K.1    Phelps, D.A.2    Xaio, L.3    Guttridge, D.C.4    Lin, J.5    London, C.6
  • 10
    • 84872872856 scopus 로고    scopus 로고
    • Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model
    • Bidwell, G. L. III, Perkins, E., Hughes, J., Khan, M., James, J. R., and Raucher, D. (2013). Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS ONE 8:e55104. doi: 10.1371/journal.pone.0055104
    • (2013) PLoS ONE , vol.8
    • Bidwell, G.L.1    Perkins, E.2    Hughes, J.3    Khan, M.4    James, J.R.5    Raucher, D.6
  • 11
    • 84859505371 scopus 로고    scopus 로고
    • A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth
    • Bidwell, G. L. III, Perkins, E., and Raucher, D. (2012). A thermally targeted c-Myc inhibitory polypeptide inhibits breast tumor growth. Cancer Lett. 319, 136-143. doi: 10.1016/j.canlet.2011.12.042
    • (2012) Cancer Lett , vol.319 , pp. 136-143
    • Bidwell, G.L.1    Perkins, E.2    Raucher, D.3
  • 12
    • 84880042989 scopus 로고    scopus 로고
    • Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma
    • Brockmann, M., Poon, E., Berry, T., Carstensen, A., Deubzer, H. E., Rycak, L., et al. (2013). Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma. Cancer Cell 24, 75-89. doi: 10.1016/j.ccr.2013.05.005
    • (2013) Cancer Cell , vol.24 , pp. 75-89
    • Brockmann, M.1    Poon, E.2    Berry, T.3    Carstensen, A.4    Deubzer, H.E.5    Rycak, L.6
  • 13
    • 70549099970 scopus 로고    scopus 로고
    • The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics
    • Brooks, T. A., and Hurley, L. H. (2009). The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics. Nat. Rev. Cancer 9, 849-861. doi: 10.1038/nrc2733
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 849-861
    • Brooks, T.A.1    Hurley, L.H.2
  • 14
    • 79952763614 scopus 로고    scopus 로고
    • Targeting MYC expression through G-quadruplexes
    • Brooks, T. A., and Hurley, L. H. (2010). Targeting MYC expression through G-quadruplexes. Genes Cancer 1, 641-649. doi: 10.1177/1947601910377493
    • (2010) Genes Cancer , vol.1 , pp. 641-649
    • Brooks, T.A.1    Hurley, L.H.2
  • 15
    • 81755172447 scopus 로고    scopus 로고
    • Demonstration that drug-targeted down-regulation of MYC in non-hodgkins lymphoma is directly mediated through the promoter G-quadruplex
    • Brown, R. V., Danford, F. L., Gokhale, V., Hurley, L. H., and Brooks, T. A. (2011). Demonstration that drug-targeted down-regulation of MYC in non-hodgkins lymphoma is directly mediated through the promoter G-quadruplex. J. Biol. Chem. 286, 41018-41027. doi: 10.1074/jbc. M111.274720
    • (2011) J. Biol. Chem , vol.286 , pp. 41018-41027
    • Brown, R.V.1    Danford, F.L.2    Gokhale, V.3    Hurley, L.H.4    Brooks, T.A.5
  • 17
    • 84922784813 scopus 로고    scopus 로고
    • Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis
    • Carroll, P. A., Diolaiti, D., McFerrin, L., Gu, H., Djukovic, D., Du, J., et al. (2015). Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell 27, 271-285. doi: 10.1016/j.ccell.2014.11.024
    • (2015) Cancer Cell , vol.27 , pp. 271-285
    • Carroll, P.A.1    Diolaiti, D.2    McFerrin, L.3    Gu, H.4    Djukovic, D.5    Du, J.6
  • 18
    • 84960842480 scopus 로고    scopus 로고
    • MYC regulates the antitumor immune response through CD47 and PD-L1
    • Casey, S. C., Tong, L., Li, Y., Do, R., Walz, S., Fitzgerald, K. N., et al. (2016). MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352, 227-231. doi: 10.1126/science.aac9935
    • (2016) Science , vol.352 , pp. 227-231
    • Casey, S.C.1    Tong, L.2    Li, Y.3    Do, R.4    Walz, S.5    Fitzgerald, K.N.6
  • 19
    • 84897583716 scopus 로고    scopus 로고
    • Synthetic lethal screens as a means to understand and treat MYC-driven cancers
    • Cermelli, S., Jang, I. S., Bernard, B., and Grandori, C. (2014). Synthetic lethal screens as a means to understand and treat MYC-driven cancers. Cold Spring Harb. Perspect. Med. 4:a014209. doi: 10.1101/cshperspect.a014209
    • (2014) Cold Spring Harb. Perspect. Med , vol.4
    • Cermelli, S.1    Jang, I.S.2    Bernard, B.3    Grandori, C.4
  • 20
    • 84907863913 scopus 로고    scopus 로고
    • Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1, 2, 5]oxadiazol-4-yl)-[1, 1'-biphenyl]-3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerization
    • Chauhan, J., Wang, H., Yap, J. L., Sabato, P. E., Hu, A., Prochownik, E. V., et al. (2014). Discovery of methyl 4'-methyl-5-(7-nitrobenzo[c][1, 2, 5]oxadiazol-4-yl)-[1, 1'-biphenyl]-3-carboxylate, an improved small-molecule inhibitor of c-Myc-max dimerization. ChemMedChem 9, 2274-2285. doi: 10.1002/cmdc.201402189
    • (2014) ChemMedChem , vol.9 , pp. 2274-2285
    • Chauhan, J.1    Wang, H.2    Yap, J.L.3    Sabato, P.E.4    Hu, A.5    Prochownik, E.V.6
  • 21
    • 84907879938 scopus 로고    scopus 로고
    • Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics
    • Chen, B. J., Wu, Y. L., Tanaka, Y., and Zhang, W. (2014). Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics. Int. J. Biol. Sci. 10, 1084-1096. doi: 10.7150/ijbs.10190
    • (2014) Int. J. Biol. Sci , vol.10 , pp. 1084-1096
    • Chen, B.J.1    Wu, Y.L.2    Tanaka, Y.3    Zhang, W.4
  • 22
    • 84911942289 scopus 로고    scopus 로고
    • CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer
    • Chipumuro, E., Marco, E., Christensen, C. L., Kwiatkowski, N., Zhang, T., Hatheway, C. M., et al. (2014). CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer. Cell 159, 1126-1139. doi: 10.1016/j.cell.2014.10.024
    • (2014) Cell , vol.159 , pp. 1126-1139
    • Chipumuro, E.1    Marco, E.2    Christensen, C.L.3    Kwiatkowski, N.4    Zhang, T.5    Hatheway, C.M.6
  • 23
    • 84919495606 scopus 로고    scopus 로고
    • Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor
    • Christensen, C. L., Kwiatkowski, N., Abraham, B. J., Carretero, J., Al-Shahrour, F., Zhang, T., et al. (2014). Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell 26, 909-922. doi: 10.1016/j.ccell.2014.10.019
    • (2014) Cancer Cell , vol.26 , pp. 909-922
    • Christensen, C.L.1    Kwiatkowski, N.2    Abraham, B.J.3    Carretero, J.4    Al-Shahrour, F.5    Zhang, T.6
  • 24
    • 78649567717 scopus 로고    scopus 로고
    • In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization
    • Clausen, D. M., Guo, J., Parise, R. A., Beumer, J. H., Egorin, M. J., Lazo, J. S., et al. (2010). In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization. J. Pharmacol. Exp. Ther. 335, 715-727. doi: 10.1124/jpet.110.170555
    • (2010) J. Pharmacol. Exp. Ther , vol.335 , pp. 715-727
    • Clausen, D.M.1    Guo, J.2    Parise, R.A.3    Beumer, J.H.4    Egorin, M.J.5    Lazo, J.S.6
  • 26
    • 84880951110 scopus 로고    scopus 로고
    • In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models
    • Conde, J., Tian, F., Hernández, Y., Bao, C., Cui, D., Janssen, K. P., et al. (2013). In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models. Biomaterials 34, 7744-7753. doi: 10.1016/j.biomaterials.2013.06.041
    • (2013) Biomaterials , vol.34 , pp. 7744-7753
    • Conde, J.1    Tian, F.2    Hernández, Y.3    Bao, C.4    Cui, D.5    Janssen, K.P.6
  • 27
    • 84859171807 scopus 로고    scopus 로고
    • MYC on the path to cancer
    • Dang, C. V. (2012). MYC on the path to cancer. Cell 149, 22-35. doi: 10.1016/j.cell.2012.03.003
    • (2012) Cell , vol.149 , pp. 22-35
    • Dang, C.V.1
  • 28
    • 84881056831 scopus 로고    scopus 로고
    • MYC, metabolism, cell growth, and tumorigenesis
    • Dang, C. V. (2013). MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb. Perspect. Med. 3:a014217. doi: 10.1101/cshperspect.a014217
    • (2013) Cold Spring Harb. Perspect. Med , vol.3
    • Dang, C.V.1
  • 29
    • 80052955256 scopus 로고    scopus 로고
    • BET bromodomain inhibition as a therapeutic strategy to target c-Myc
    • Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., et al. (2011). BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917. doi: 10.1016/j.cell.2011.08.017
    • (2011) Cell , vol.146 , pp. 904-917
    • Delmore, J.E.1    Issa, G.C.2    Lemieux, M.E.3    Rahl, P.B.4    Shi, J.5    Jacobs, H.M.6
  • 30
    • 77956588949 scopus 로고    scopus 로고
    • Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
    • den Hollander, J., Rimpi, S., Doherty, J. R., Rudelius, M., Buck, A., Hoellein, A., et al. (2010). Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood 116, 1498-1505. doi: 10.1182/blood-2009-11-251074
    • (2010) Blood , vol.116 , pp. 1498-1505
    • den Hollander, J.1    Rimpi, S.2    Doherty, J.R.3    Rudelius, M.4    Buck, A.5    Hoellein, A.6
  • 31
    • 18844429452 scopus 로고    scopus 로고
    • In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors
    • Devi, G. R., Beer, T. M., Corless, C. L., Arora, V., Weller, D. L., and Iversen, P. L. (2005). In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors. Clin. Cancer Res. 11, 3930-3938. doi: 10.1158/1078-0432.CCR-04-2091
    • (2005) Clin. Cancer Res , vol.11 , pp. 3930-3938
    • Devi, G.R.1    Beer, T.M.2    Corless, C.L.3    Arora, V.4    Weller, D.L.5    Iversen, P.L.6
  • 32
    • 84979300705 scopus 로고    scopus 로고
    • Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors
    • Donato, E., Croci, O., Sabò, A., Muller, H., Morelli, M. J., Pelizzola, M., et al. (2017). Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Leukemia 31, 479-490. doi: 10.1038/leu.2016.182
    • (2017) Leukemia , vol.31 , pp. 479-490
    • Donato, E.1    Croci, O.2    Sabò, A.3    Muller, H.4    Morelli, M.J.5    Pelizzola, M.6
  • 33
    • 79951847459 scopus 로고    scopus 로고
    • Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth
    • Drygin, D., Lin, A., Bliesath, J., Ho, C. B., O'Brien, S. E., Proffitt, C., et al. (2011). Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res. 71, 1418-1430. doi: 10.1158/0008-5472.CAN-10-1728
    • (2011) Cancer Res , vol.71 , pp. 1418-1430
    • Drygin, D.1    Lin, A.2    Bliesath, J.3    Ho, C.B.4    O'Brien, S.E.5    Proffitt, C.6
  • 35
    • 84902676509 scopus 로고    scopus 로고
    • Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer
    • Farrell, A. S., Allen-Petersen, B., Daniel, C. J., Wang, X., Wang, Z., Rodriguez, S., et al. (2014). Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer. Mol. Cancer Res. 12, 924-939. doi: 10.1158/1541-7786.MCR-13-0542
    • (2014) Mol. Cancer Res , vol.12 , pp. 924-939
    • Farrell, A.S.1    Allen-Petersen, B.2    Daniel, C.J.3    Wang, X.4    Wang, Z.5    Rodriguez, S.6
  • 36
    • 84954470546 scopus 로고    scopus 로고
    • Small molecule microarrays enable the identification of a selective, quadruplex-binding inhibitor of MYC expression
    • Felsenstein, K. M., Saunders, L. B., Simmons, J. K., Leon, E., Calabrese, D. R., Zhang, S., et al. (2016). Small molecule microarrays enable the identification of a selective, quadruplex-binding inhibitor of MYC expression. ACS Chem. Biol. 11, 139-148. doi: 10.1021/acschembio.5b00577
    • (2016) ACS Chem. Biol , vol.11 , pp. 139-148
    • Felsenstein, K.M.1    Saunders, L.B.2    Simmons, J.K.3    Leon, E.4    Calabrese, D.R.5    Zhang, S.6
  • 37
    • 84859428543 scopus 로고    scopus 로고
    • Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
    • Ferrao, P. T., Bukczynska, E. P., Johnstone, R. W., and McArthur, G. A. (2012). Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells. Oncogene 31, 1661-1672. doi: 10.1038/onc.2011.358
    • (2012) Oncogene , vol.31 , pp. 1661-1672
    • Ferrao, P.T.1    Bukczynska, E.P.2    Johnstone, R.W.3    McArthur, G.A.4
  • 38
    • 84971508916 scopus 로고    scopus 로고
    • Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
    • Fiorentino, F. P., Tokgüun, E., Solé-Sánchez, S., Giampaolo, S., Tokgun, O., Jauset, T., et al. (2016). Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation. Oncotarget 7, 31014-31028. doi: 10.18632/oncotarget.8826
    • (2016) Oncotarget , vol.7 , pp. 31014-31028
    • Fiorentino, F.P.1    Tokgüun, E.2    Solé-Sánchez, S.3    Giampaolo, S.4    Tokgun, O.5    Jauset, T.6
  • 39
    • 84898707339 scopus 로고    scopus 로고
    • Small-molecule inhibitors of the Myc oncoprotein
    • Fletcher, S., and Prochownik, E. V. (2015). Small-molecule inhibitors of the Myc oncoprotein. Biochim. Biophys. Acta 1849, 525-543. doi: 10.1016/j.bbagrm.2014.03.005
    • (2015) Biochim. Biophys. Acta , vol.1849 , pp. 525-543
    • Fletcher, S.1    Prochownik, E.V.2
  • 40
    • 56049097680 scopus 로고    scopus 로고
    • Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules
    • Follis, A. V., Hammoudeh, D. I., Wang, H., Prochownik, E. V., and Metallo, S. J. (2008). Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules. Chem. Biol. 15, 1149-1155. doi: 10.1016/j.chembiol.2008.09.011
    • (2008) Chem. Biol , vol.15 , pp. 1149-1155
    • Follis, A.V.1    Hammoudeh, D.I.2    Wang, H.3    Prochownik, E.V.4    Metallo, S.J.5
  • 41
    • 84942531832 scopus 로고    scopus 로고
    • BET inhibitor resistance emerges from leukaemia stem cells
    • Fong, C. Y., Gilan, O., Lam, E. Y., Rubin, A. F., Ftouni, S., Tyler, D., et al. (2015). BET inhibitor resistance emerges from leukaemia stem cells. Nature 525, 538-542. doi: 10.1038/nature14888
    • (2015) Nature , vol.525 , pp. 538-542
    • Fong, C.Y.1    Gilan, O.2    Lam, E.Y.3    Rubin, A.F.4    Ftouni, S.5    Tyler, D.6
  • 42
    • 84999740010 scopus 로고    scopus 로고
    • Resetting cancer stem cell regulatory nodes upon MYC inhibition
    • Galardi, S., Savino, M., Scagnoli, F., Pellegatta, S., Pisati, F., Zambelli, F., et al. (2016). Resetting cancer stem cell regulatory nodes upon MYC inhibition. EMBO Rep. 17, 1872-1889. doi: 10.15252/embr.201541489
    • (2016) EMBO Rep , vol.17 , pp. 1872-1889
    • Galardi, S.1    Savino, M.2    Scagnoli, F.3    Pellegatta, S.4    Pisati, F.5    Zambelli, F.6
  • 43
    • 84958667694 scopus 로고    scopus 로고
    • The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models
    • Garcia, P. L., Miller, A. L., Kreitzburg, K. M., Council, L. N., Gamblin, T. L., Christein, J. D., et al. (2016). The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models. Oncogene 35, 833-845. doi: 10.1038/onc.2015.126
    • (2016) Oncogene , vol.35 , pp. 833-845
    • Garcia, P.L.1    Miller, A.L.2    Kreitzburg, K.M.3    Council, L.N.4    Gamblin, T.L.5    Christein, J.D.6
  • 44
    • 17944392627 scopus 로고    scopus 로고
    • Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence
    • Giorello, L., Clerico, L., Pescarolo, M. P., Vikhanskaya, F., Salmona, M., Colella, G., et al. (1998). Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res. 58, 3654-3659
    • (1998) Cancer Res , vol.58 , pp. 3654-3659
    • Giorello, L.1    Clerico, L.2    Pescarolo, M.P.3    Vikhanskaya, F.4    Salmona, M.5    Colella, G.6
  • 45
    • 34447137342 scopus 로고    scopus 로고
    • Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
    • Goga, A., Yang, D., Tward, A. D., Morgan, D. O., and Bishop, J. M. (2007). Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat. Med. 13, 820-827. doi: 10.1038/nm1606
    • (2007) Nat. Med , vol.13 , pp. 820-827
    • Goga, A.1    Yang, D.2    Tward, A.D.3    Morgan, D.O.4    Bishop, J.M.5
  • 46
    • 58849157916 scopus 로고    scopus 로고
    • Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z, E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice
    • Guo, J., Parise, R. A., Joseph, E., Egorin, M. J., Lazo, J. S., Prochownik, E. V., et al. (2009). Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z, E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice. Cancer Chemother. Pharmacol. 63, 615-625. doi: 10.1007/s00280-008-0774-y
    • (2009) Cancer Chemother. Pharmacol , vol.63 , pp. 615-625
    • Guo, J.1    Parise, R.A.2    Joseph, E.3    Egorin, M.J.4    Lazo, J.S.5    Prochownik, E.V.6
  • 47
    • 84971667868 scopus 로고    scopus 로고
    • microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13
    • Han, H., Chen, Y., Cheng, L., Prochownik, E. V., and Li, Y. (2016). microRNA-206 impairs c-Myc-driven cancer in a synthetic lethal manner by directly inhibiting MAP3K13. Oncotarget 7, 16409-16419. doi: 10.18632/oncotarget.7653
    • (2016) Oncotarget , vol.7 , pp. 16409-16419
    • Han, H.1    Chen, Y.2    Cheng, L.3    Prochownik, E.V.4    Li, Y.5
  • 48
    • 84906674331 scopus 로고    scopus 로고
    • Inhibitor of MYC identified in a Krohnke pyridine library
    • Hart, J. R., Garner, A. L., Yu, J., Ito, Y., Sun, M., Ueno, L., et al. (2014). Inhibitor of MYC identified in a Krohnke pyridine library. Proc. Natl. Acad. Sci. U.S.A. 111, 12556-12561. doi: 10.1073/pnas.1319488111
    • (2014) Proc. Natl. Acad. Sci. U.S.A , vol.111 , pp. 12556-12561
    • Hart, J.R.1    Garner, A.L.2    Yu, J.3    Ito, Y.4    Sun, M.5    Ueno, L.6
  • 49
    • 84982812922 scopus 로고    scopus 로고
    • The quest for targets executing MYC-dependent cell transformation
    • Hartl, M. (2016). The quest for targets executing MYC-dependent cell transformation. Front. Oncol. 6:132. doi: 10.3389/fonc.2016.00132
    • (2016) Front. Oncol , vol.6 , pp. 132
    • Hartl, M.1
  • 51
    • 84990935124 scopus 로고    scopus 로고
    • BET inhibition induces apoptosis in aggressive B-cell lymphoma via epigenetic regulation of BCL-2 family members
    • Hogg, S. J., Newbold, A., Vervoort, S. J., Cluse, L. A., Martin, B. P., Gregory, G. P., et al. (2016). BET inhibition induces apoptosis in aggressive B-cell lymphoma via epigenetic regulation of BCL-2 family members. Mol. Cancer Ther. 15, 2030-2041. doi: 10.1158/1535-7163.MCT-15-0924
    • (2016) Mol. Cancer Ther , vol.15 , pp. 2030-2041
    • Hogg, S.J.1    Newbold, A.2    Vervoort, S.J.3    Cluse, L.A.4    Martin, B.P.5    Gregory, G.P.6
  • 52
    • 84992376478 scopus 로고    scopus 로고
    • PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
    • Horiuchi, D., Camarda, R., Zhou, A. Y., Yau, C., Momcilovic, O., Balakrishnan, S., et al. (2016). PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression. Nat. Med. 22, 1321-1329. doi: 10.1038/nm.4213
    • (2016) Nat. Med , vol.22 , pp. 1321-1329
    • Horiuchi, D.1    Camarda, R.2    Zhou, A.Y.3    Yau, C.4    Momcilovic, O.5    Balakrishnan, S.6
  • 53
    • 84984623465 scopus 로고    scopus 로고
    • MYC, metabolic synthetic lethality, and cancer
    • Hsieh, A. L., and Dang, C. V. (2016). MYC, metabolic synthetic lethality, and cancer. Recent Results Cancer Res. 207, 73-91. doi: 10.1007/978-3-319-42118-6_4
    • (2016) Recent Results Cancer Res , vol.207 , pp. 73-91
    • Hsieh, A.L.1    Dang, C.V.2
  • 54
    • 84906074303 scopus 로고    scopus 로고
    • CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
    • Huang, C. H., Lujambio, A., Zuber, J., Tschaharganeh, D. F., Doran, M. G., Evans, M. J., et al. (2014). CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma. Genes Dev. 28, 1800-1814. doi: 10.1101/gad.244368.114
    • (2014) Genes Dev , vol.28 , pp. 1800-1814
    • Huang, C.H.1    Lujambio, A.2    Zuber, J.3    Tschaharganeh, D.F.4    Doran, M.G.5    Evans, M.J.6
  • 55
    • 84862731787 scopus 로고    scopus 로고
    • Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis
    • Huang, H. L., Weng, H. Y., Wang, L. Q., Yu, C. H., Huang, Q. J., Zhao, P. P., et al. (2012). Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Mol. Cancer Ther. 11, 1155-1165. doi: 10.1158/1535-7163.MCT-12-0066
    • (2012) Mol. Cancer Ther , vol.11 , pp. 1155-1165
    • Huang, H.L.1    Weng, H.Y.2    Wang, L.Q.3    Yu, C.H.4    Huang, Q.J.5    Zhao, P.P.6
  • 56
    • 76249101395 scopus 로고    scopus 로고
    • Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
    • Hydbring, P., Bahram, F., Su, Y., Tronnersjo, S., Hogstrand, K., von der Lehr, N., et al. (2010). Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc. Natl. Acad. Sci. U.S.A. 107, 58-63. doi: 10.1073/pnas.0900121106
    • (2010) Proc. Natl. Acad. Sci. U.S.A , vol.107 , pp. 58-63
    • Hydbring, P.1    Bahram, F.2    Su, Y.3    Tronnersjo, S.4    Hogstrand, K.5    von der Lehr, N.6
  • 57
    • 84955114584 scopus 로고    scopus 로고
    • Src inhibition blocks c-Myc translation and glucose metabolism to prevent the development of breast cancer
    • Jain, S., Wang, X., Chang, C. C., Ibarra-Drendall, C., Wang, H., Zhang, Q., et al. (2015). Src inhibition blocks c-Myc translation and glucose metabolism to prevent the development of breast cancer. Cancer Res. 75, 4863-4875. doi: 10.1158/0008-5472.CAN-14-2345
    • (2015) Cancer Res , vol.75 , pp. 4863-4875
    • Jain, S.1    Wang, X.2    Chang, C.C.3    Ibarra-Drendall, C.4    Wang, H.5    Zhang, Q.6
  • 59
    • 84891904422 scopus 로고    scopus 로고
    • Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth
    • Jeong, K. C., Kim, K. T., Seo, H. H., Shin, S. P., Ahn, K. O., Ji, M. J., et al. (2014). Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth. J. Urol. 191, 510-518. doi: 10.1016/j.juro.2013.07.019
    • (2014) J. Urol , vol.191 , pp. 510-518
    • Jeong, K.C.1    Kim, K.T.2    Seo, H.H.3    Shin, S.P.4    Ahn, K.O.5    Ji, M.J.6
  • 60
    • 69549124720 scopus 로고    scopus 로고
    • Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function
    • Jiang, H., Bower, K. E., Beuscher, A. E., Zhou, B., Bobkov, A. A., Olson, A. J., et al. (2009). Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function. Mol. Pharmacol. 76, 491-502. doi: 10.1124/mol.109.054858
    • (2009) Mol. Pharmacol , vol.76 , pp. 491-502
    • Jiang, H.1    Bower, K.E.2    Beuscher, A.E.3    Zhou, B.4    Bobkov, A.A.5    Olson, A.J.6
  • 61
    • 84927582243 scopus 로고    scopus 로고
    • Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics
    • Jung, K. Y., Wang, H., Teriete, P., Yap, J. L., Chen, L., Lanning, M. E., et al. (2015). Perturbation of the c-Myc-Max protein-protein interaction via synthetic α-helix mimetics. J. Med. Chem. 58, 3002-3024. doi: 10.1021/jm501440q
    • (2015) J. Med. Chem , vol.58 , pp. 3002-3024
    • Jung, K.Y.1    Wang, H.2    Teriete, P.3    Yap, J.L.4    Chen, L.5    Lanning, M.E.6
  • 62
    • 84856069665 scopus 로고    scopus 로고
    • A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis
    • Kessler, J. D., Kahle, K. T., Sun, T., Meerbrey, K. L., Schlabach, M. R., Schmitt, E. M., et al. (2012). A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science 335, 348-353. doi: 10.1126/science.1212728
    • (2012) Science , vol.335 , pp. 348-353
    • Kessler, J.D.1    Kahle, K.T.2    Sun, T.3    Meerbrey, K.L.4    Schlabach, M.R.5    Schmitt, E.M.6
  • 63
    • 36348962617 scopus 로고    scopus 로고
    • First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study
    • Kipshidze, N., Iversen, P., Overlie, P., Dunlap, T., Titus, B., Lee, D., et al. (2007). First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and angiographic follow-up from AVAIL study. Cardiovasc. Revasc. Med. 8, 230-235. doi: 10.1016/j.carrev.2007.04.002
    • (2007) Cardiovasc. Revasc. Med , vol.8 , pp. 230-235
    • Kipshidze, N.1    Iversen, P.2    Overlie, P.3    Dunlap, T.4    Titus, B.5    Lee, D.6
  • 64
    • 12144288392 scopus 로고    scopus 로고
    • Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model
    • Kipshidze, N. N., Iversen, P., Kim, H. S., Yiazdi, H., Dangas, G., Seaborn, R., et al. (2004). Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model. Catheter. Cardiovasc. Interv. 61, 518-527. doi: 10.1002/ccd.20007
    • (2004) Catheter. Cardiovasc. Interv , vol.61 , pp. 518-527
    • Kipshidze, N.N.1    Iversen, P.2    Kim, H.S.3    Yiazdi, H.4    Dangas, G.5    Seaborn, R.6
  • 65
    • 10744229758 scopus 로고    scopus 로고
    • Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model
    • Kipshidze, N. N., Porter, T. R., Dangas, G., Yazdi, H., Tio, F., Xie, F., et al. (2003). Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model. Cardiovasc. Radiat. Med. 4, 152-159. doi: 10.1016/S1522-1865(03)00184-7
    • (2003) Cardiovasc. Radiat. Med , vol.4 , pp. 152-159
    • Kipshidze, N.N.1    Porter, T.R.2    Dangas, G.3    Yazdi, H.4    Tio, F.5    Xie, F.6
  • 66
    • 84968343089 scopus 로고    scopus 로고
    • Targeting MYC in cancer therapy: RNA processing offers new opportunities
    • Koh, C. M., Sabo, A., and Guccione, E. (2016). Targeting MYC in cancer therapy: RNA processing offers new opportunities. Bioessays 38, 266-275. doi: 10.1002/bies.201500134
    • (2016) Bioessays , vol.38 , pp. 266-275
    • Koh, C.M.1    Sabo, A.2    Guccione, E.3
  • 67
    • 84958115640 scopus 로고    scopus 로고
    • Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping
    • Kumar, A., Ito, A., Hirohama, M., Yoshida, M., and Zhang, K. Y. (2016). Identification of new SUMO activating enzyme 1 inhibitors using virtual screening and scaffold hopping. Bioorg. Med. Chem. Lett. 26, 1218-1223. doi: 10.1016/j.bmcl.2016.01.030
    • (2016) Bioorg. Med. Chem. Lett , vol.26 , pp. 1218-1223
    • Kumar, A.1    Ito, A.2    Hirohama, M.3    Yoshida, M.4    Zhang, K.Y.5
  • 68
    • 84904963991 scopus 로고    scopus 로고
    • Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
    • Kwiatkowski, N., Zhang, T., Rahl, P. B., Abraham, B. J., Reddy, J., Ficarro, S. B., et al. (2014). Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 511, 616-620. doi: 10.1038/nature13393
    • (2014) Nature , vol.511 , pp. 616-620
    • Kwiatkowski, N.1    Zhang, T.2    Rahl, P.B.3    Abraham, B.J.4    Reddy, J.5    Ficarro, S.B.6
  • 69
    • 67650073265 scopus 로고    scopus 로고
    • Cell cycle kinases as therapeutic targets for cancer
    • Lapenna, S., and Giordano, A. (2009). Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 8, 547-566. doi: 10.1038/nrd2907
    • (2009) Nat. Rev. Drug Discov , vol.8 , pp. 547-566
    • Lapenna, S.1    Giordano, A.2
  • 70
    • 84954170474 scopus 로고    scopus 로고
    • Drugging undruggable molecular cancer targets
    • Lazo, J. S., and Sharlow, E. R. (2016). Drugging undruggable molecular cancer targets. Annu. Rev. Pharmacol. Toxicol. 56, 23-40. doi: 10.1146/annurev-pharmtox-010715-103440
    • (2016) Annu. Rev. Pharmacol. Toxicol , vol.56 , pp. 23-40
    • Lazo, J.S.1    Sharlow, E.R.2
  • 71
    • 84964324549 scopus 로고    scopus 로고
    • Time-staggered delivery of docetaxel and H1-S6A, F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting
    • Li, L., Sun, W., Zhang, Z., and Huang, Y. (2016). Time-staggered delivery of docetaxel and H1-S6A, F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting. J. Control. Release 232, 62-74. doi: 10.1016/j.jconrel.2016.04.021
    • (2016) J. Control. Release , vol.232 , pp. 62-74
    • Li, L.1    Sun, W.2    Zhang, Z.3    Huang, Y.4
  • 72
    • 84931095298 scopus 로고    scopus 로고
    • MYC-mediated synthetic lethality for treating tumors
    • Li, X., Zhang, X. A., Li, X., Xie, W., and Huang, S. (2015). MYC-mediated synthetic lethality for treating tumors. Curr. Cancer Drug Targets 15, 99-115. doi: 10.2174/1568009615666150121162921
    • (2015) Curr. Cancer Drug Targets , vol.15 , pp. 99-115
    • Li, X.1    Zhang, X.A.2    Li, X.3    Xie, W.4    Huang, S.5
  • 73
    • 84878284102 scopus 로고    scopus 로고
    • Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth
    • Li, Y., Zhang, B., Zhang, H., Zhu, X., Feng, D., Zhang, D., et al. (2013). Oncolytic adenovirus armed with shRNA targeting MYCN gene inhibits neuroblastoma cell proliferation and in vivo xenograft tumor growth. J. Cancer Res. Clin. Oncol. 139, 933-941. doi: 10.1007/s00432-013-1406-4
    • (2013) J. Cancer Res. Clin. Oncol , vol.139 , pp. 933-941
    • Li, Y.1    Zhang, B.2    Zhang, H.3    Zhu, X.4    Feng, D.5    Zhang, D.6
  • 74
    • 84859167179 scopus 로고    scopus 로고
    • Deregulated MYC expression induces dependence upon AMPK-related kinase 5
    • Liu, L., Ulbrich, J., Muller, J., Wustefeld, T., Aeberhard, L., Kress, T. R., et al. (2012). Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483, 608-612. doi: 10.1038/nature10927
    • (2012) Nature , vol.483 , pp. 608-612
    • Liu, L.1    Ulbrich, J.2    Muller, J.3    Wustefeld, T.4    Aeberhard, L.5    Kress, T.R.6
  • 75
    • 84876222028 scopus 로고    scopus 로고
    • Selective inhibition of tumor oncogenes by disruption of super-enhancers
    • Loven, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., et al. (2013). Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320-334. doi: 10.1016/j.cell.2013.03.036
    • (2013) Cell , vol.153 , pp. 320-334
    • Loven, J.1    Hoke, H.A.2    Lin, C.Y.3    Lau, A.4    Orlando, D.A.5    Vakoc, C.R.6
  • 76
    • 77958042173 scopus 로고    scopus 로고
    • Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics
    • Macarulla, T., Cervantes, A., Elez, E., Rodriguez-Braun, E., Baselga, J., Rosello, S., et al. (2010). Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics. Mol. Cancer Ther. 9, 2844-2852. doi: 10.1158/1535-7163.MCT-10-0299
    • (2010) Mol. Cancer Ther , vol.9 , pp. 2844-2852
    • Macarulla, T.1    Cervantes, A.2    Elez, E.3    Rodriguez-Braun, E.4    Baselga, J.5    Rosello, S.6
  • 77
    • 84978292954 scopus 로고    scopus 로고
    • Ibrutinib repurposing: from B-cell malignancies to solid tumors
    • Massó-Vallés, D., Jauset, T., and Soucek, L. (2016). Ibrutinib repurposing: from B-cell malignancies to solid tumors. Oncoscience 3, 147-148. doi: 10.18632/oncoscience.310
    • (2016) Oncoscience , vol.3 , pp. 147-148
    • Massó-Vallés, D.1    Jauset, T.2    Soucek, L.3
  • 80
    • 56749184298 scopus 로고    scopus 로고
    • Reflecting on 25 years with MYC
    • Meyer, N., and Penn, L. Z. (2008). Reflecting on 25 years with MYC. Nat. Rev. Cancer 8, 976-990. doi: 10.1038/nrc2231
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 976-990
    • Meyer, N.1    Penn, L.Z.2
  • 81
    • 33646551232 scopus 로고    scopus 로고
    • Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation
    • Mo, H., and Henriksson, M. (2006). Identification of small molecules that induce apoptosis in a Myc-dependent manner and inhibit Myc-driven transformation. Proc. Natl. Acad. Sci. U.S.A. 103, 6344-6349. doi: 10.1073/pnas.0601418103
    • (2006) Proc. Natl. Acad. Sci. U.S.A , vol.103 , pp. 6344-6349
    • Mo, H.1    Henriksson, M.2
  • 82
    • 33749599777 scopus 로고    scopus 로고
    • Myc overexpression enhances apoptosis induced by small molecules
    • Mo, H., Vita, M., Crespin, M., and Henriksson, M. A. (2006). Myc overexpression enhances apoptosis induced by small molecules. Cell Cycle 5, 2191-2194. doi: 10.4161/cc.5.19.3320
    • (2006) Cell Cycle , vol.5 , pp. 2191-2194
    • Mo, H.1    Vita, M.2    Crespin, M.3    Henriksson, M.A.4
  • 83
    • 84857497763 scopus 로고    scopus 로고
    • The max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities
    • Montagne, M., Beaudoin, N., Fortin, D., Lavoie, C. L., Klinck, R., and Lavigne, P. (2012). The max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities. PLoS ONE 7:e32172. doi: 10.1371/journal.pone.0032172
    • (2012) PLoS ONE , vol.7
    • Montagne, M.1    Beaudoin, N.2    Fortin, D.3    Lavoie, C.L.4    Klinck, R.5    Lavigne, P.6
  • 84
    • 84987630012 scopus 로고    scopus 로고
    • Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
    • Moreno, P. M., and Pego, A. P. (2014). Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic. Front. Chem. 2:87. doi: 10.3389/fchem.2014.00087
    • (2014) Front. Chem , vol.2 , pp. 87
    • Moreno, P.M.1    Pego, A.P.2
  • 85
    • 82955203422 scopus 로고    scopus 로고
    • Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors
    • Murga, M., Campaner, S., Lopez-Contreras, A. J., Toledo, L. I., Soria, R., Montana, M. F., et al. (2011). Exploiting oncogene-induced replicative stress for the selective killing of Myc-driven tumors. Nat. Struct. Mol. Biol. 18, 1331-1335. doi: 10.1038/nsmb.2189
    • (2011) Nat. Struct. Mol. Biol , vol.18 , pp. 1331-1335
    • Murga, M.1    Campaner, S.2    Lopez-Contreras, A.J.3    Toledo, L.I.4    Soria, R.5    Montana, M.F.6
  • 87
    • 0031452563 scopus 로고    scopus 로고
    • Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site
    • Nanbru, C., Lafon, I., Audigier, S., Gensac, M. C., Vagner, S., Huez, G., et al. (1997). Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J. Biol. Chem. 272, 32061-32066
    • (1997) J. Biol. Chem , vol.272 , pp. 32061-32066
    • Nanbru, C.1    Lafon, I.2    Audigier, S.3    Gensac, M.C.4    Vagner, S.5    Huez, G.6
  • 88
    • 84978759686 scopus 로고    scopus 로고
    • Quadruplex nucleic acids as novel therapeutic targets
    • Neidle, S. (2016). Quadruplex nucleic acids as novel therapeutic targets. J. Med. Chem. 59, 5987-6011. doi: 10.1021/acs.jmedchem.5b01835
    • (2016) J. Med. Chem , vol.59 , pp. 5987-6011
    • Neidle, S.1
  • 89
    • 84939530621 scopus 로고    scopus 로고
    • THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
    • Nilson, K. A., Guo, J., Turek, M. E., Brogie, J. E., Delaney, E., Luse, D. S., et al. (2015). THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing. Mol. Cell 59, 576-587. doi: 10.1016/j.molcel.2015.06.032
    • (2015) Mol. Cell , vol.59 , pp. 576-587
    • Nilson, K.A.1    Guo, J.2    Turek, M.E.3    Brogie, J.E.4    Delaney, E.5    Luse, D.S.6
  • 90
    • 0041854279 scopus 로고    scopus 로고
    • Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice
    • Ortega, S., Prieto, I., Odajima, J., Martin, A., Dubus, P., Sotillo, R., et al. (2003). Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35, 25-31. doi: 10.1038/ng1232
    • (2003) Nat. Genet , vol.35 , pp. 25-31
    • Ortega, S.1    Prieto, I.2    Odajima, J.3    Martin, A.4    Dubus, P.5    Sotillo, R.6
  • 91
    • 57849107571 scopus 로고    scopus 로고
    • Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma
    • Otto, T., Horn, S., Brockmann, M., Eilers, U., Schuttrumpf, L., Popov, N., et al. (2009). Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma. Cancer Cell 15, 67-78. doi: 10.1016/j.ccr.2008.12.005
    • (2009) Cancer Cell , vol.15 , pp. 67-78
    • Otto, T.1    Horn, S.2    Brockmann, M.3    Eilers, U.4    Schuttrumpf, L.5    Popov, N.6
  • 92
    • 34147100699 scopus 로고    scopus 로고
    • Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives
    • Ou, T. M., Lu, Y. J., Zhang, C., Huang, Z. S., Wang, X. D., Tan, J. H., et al. (2007). Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives. J. Med. Chem. 50, 1465-1474. doi: 10.1021/jm0610088
    • (2007) J. Med. Chem , vol.50 , pp. 1465-1474
    • Ou, T.M.1    Lu, Y.J.2    Zhang, C.3    Huang, Z.S.4    Wang, X.D.5    Tan, J.H.6
  • 93
    • 84875182214 scopus 로고    scopus 로고
    • Oncolytic virus therapy for cancer: the first wave of translational clinical trials
    • Patel, M. R., and Kratzke, R. A. (2013). Oncolytic virus therapy for cancer: the first wave of translational clinical trials. Transl. Res. 161, 355-364. doi: 10.1016/j.trsl.2012.12.010
    • (2013) Transl. Res , vol.161 , pp. 355-364
    • Patel, M.R.1    Kratzke, R.A.2
  • 94
    • 84918519265 scopus 로고    scopus 로고
    • Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
    • Peter, S., Bultinck, J., Myant, K., Jaenicke, L. A., Walz, S., Muller, J., et al. (2014). Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol. Med. 6, 1525-1541. doi: 10.15252/emmm.201403927
    • (2014) EMBO Mol. Med , vol.6 , pp. 1525-1541
    • Peter, S.1    Bultinck, J.2    Myant, K.3    Jaenicke, L.A.4    Walz, S.5    Muller, J.6
  • 95
    • 85026835945 scopus 로고    scopus 로고
    • The appraisal-trial: evaluating RESTEN-MPTM in patients with bare metal stent de novo native coronary artery lesions
    • Philipp, S., Sack, S., Kordish, I., Brachmann, J., Hardt, S., Horn, J., et al. (2012). The appraisal-trial: evaluating RESTEN-MPTM in patients with bare metal stent de novo native coronary artery lesions. J. Clin. Exp. Cardiolog. 3:218. doi: 10.4172/2155-9880.1000218
    • (2012) J. Clin. Exp. Cardiolog , vol.3 , pp. 218
    • Philipp, S.1    Sack, S.2    Kordish, I.3    Brachmann, J.4    Hardt, S.5    Horn, J.6
  • 96
    • 53249107466 scopus 로고    scopus 로고
    • Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences
    • Pivetta, C., Lucatello, L., Krapcho, A. P., Gatto, B., Palumbo, M., and Sissi, C. (2008). Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences. Bioorg. Med. Chem. 16, 9331-9339. doi: 10.1016/j.bmc.2008.08.068
    • (2008) Bioorg. Med. Chem , vol.16 , pp. 9331-9339
    • Pivetta, C.1    Lucatello, L.2    Krapcho, A.P.3    Gatto, B.4    Palumbo, M.5    Sissi, C.6
  • 97
    • 84896401739 scopus 로고    scopus 로고
    • Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
    • Polivka, J. Jr., and Janku, F. (2014). Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Ther. 142, 164-175. doi: 10.1016/j.pharmthera.2013.12.004
    • (2014) Pharmacol. Ther , vol.142 , pp. 164-175
    • Polivka, J.1    Janku, F.2
  • 98
    • 84895417268 scopus 로고    scopus 로고
    • Targeting RNA polymerase I to treat MYC-driven cancer
    • Poortinga, G., Quinn, L. M., and Hannan, R. D. (2015). Targeting RNA polymerase I to treat MYC-driven cancer. Oncogene 34, 403-412. doi: 10.1038/onc.2014.13
    • (2015) Oncogene , vol.34 , pp. 403-412
    • Poortinga, G.1    Quinn, L.M.2    Hannan, R.D.3
  • 99
    • 84964596701 scopus 로고    scopus 로고
    • Strategically targeting MYC in cancer
    • F1000 Faculty Rev-408
    • Posternak, V., and Cole, M. D. (2016). Strategically targeting MYC in cancer. F1000Res. 5:F1000 Faculty Rev-408. doi: 10.12688/f1000research.7879.1
    • (2016) F1000Res , vol.5
    • Posternak, V.1    Cole, M.D.2
  • 100
    • 0023786827 scopus 로고
    • c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells
    • Prochownik, E. V., Kukowska, J., and Rodgers, C. (1988). c-myc antisense transcripts accelerate differentiation and inhibit G1 progression in murine erythroleukemia cells. Mol. Cell. Biol. 8, 3683-3695. doi: 10.1128/MCB.8.9.3683
    • (1988) Mol. Cell. Biol , vol.8 , pp. 3683-3695
    • Prochownik, E.V.1    Kukowska, J.2    Rodgers, C.3
  • 101
    • 79952854742 scopus 로고    scopus 로고
    • Therapeutic targeting of Myc
    • Prochownik, E. V., and Vogt, P. K. (2010). Therapeutic targeting of Myc. Genes Cancer 1, 650-659. doi: 10.1177/1947601910377494
    • (2010) Genes Cancer , vol.1 , pp. 650-659
    • Prochownik, E.V.1    Vogt, P.K.2
  • 102
    • 84942531799 scopus 로고    scopus 로고
    • Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
    • Rathert, P., Roth, M., Neumann, T., Muerdter, F., Roe, J. S., Muhar, M., et al. (2015). Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature 525, 543-547. doi: 10.1038/nature14898
    • (2015) Nature , vol.525 , pp. 543-547
    • Rathert, P.1    Roth, M.2    Neumann, T.3    Muerdter, F.4    Roe, J.S.5    Muhar, M.6
  • 105
    • 85013795282 scopus 로고    scopus 로고
    • Recent advances in targeting mTOR signaling pathway using small molecule inhibitors
    • [Epub ahead of print]
    • Roohi, A., and Hojjat-Farsangi, M. (2016). Recent advances in targeting mTOR signaling pathway using small molecule inhibitors. J. Drug Target. doi: 10.1080/1061186X.2016.1236112. [Epub ahead of print]
    • (2016) J. Drug Target
    • Roohi, A.1    Hojjat-Farsangi, M.2
  • 106
    • 79960623998 scopus 로고    scopus 로고
    • The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy
    • Savino, M., Annibali, D., Carucci, N., Favuzzi, E., Cole, M. D., Evan, G. I., et al. (2011). The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy. PLoS ONE 6:e22284. doi: 10.1371/journal.pone.0022284
    • (2011) PLoS ONE , vol.6
    • Savino, M.1    Annibali, D.2    Carucci, N.3    Favuzzi, E.4    Cole, M.D.5    Evan, G.I.6
  • 107
    • 13944252067 scopus 로고    scopus 로고
    • The life cycle of C-myc: from synthesis to degradation
    • Sears, R. C. (2004). The life cycle of C-myc: from synthesis to degradation. Cell Cycle 3, 1133-1137. doi: 10.4161/cc.3.9.1145
    • (2004) Cell Cycle , vol.3 , pp. 1133-1137
    • Sears, R.C.1
  • 108
    • 84896740334 scopus 로고    scopus 로고
    • Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
    • Seo, H. K., Ahn, K. O., Jung, N. R., Shin, J. S., Park, W. S., Lee, K. H., et al. (2014). Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer. Oncotarget 5, 326-337. doi: 10.18632/oncotarget.1545
    • (2014) Oncotarget , vol.5 , pp. 326-337
    • Seo, H.K.1    Ahn, K.O.2    Jung, N.R.3    Shin, J.S.4    Park, W.S.5    Lee, K.H.6
  • 109
    • 84962432624 scopus 로고    scopus 로고
    • Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA
    • Shaat, H., Mostafa, A., Moustafa, M., Gamal-Eldeen, A., Emam, A., El-Hussieny, E., et al. (2016). Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA. Int. J. Pharm. 504, 125-133. doi: 10.1016/j.ijpharm.2016.03.051
    • (2016) Int. J. Pharm , vol.504 , pp. 125-133
    • Shaat, H.1    Mostafa, A.2    Moustafa, M.3    Gamal-Eldeen, A.4    Emam, A.5    El-Hussieny, E.6
  • 110
    • 84953742368 scopus 로고    scopus 로고
    • MYC as therapeutic target for embryonal tumors: potential and challenges
    • Shalaby, T., and Grotzer, M. A. (2016). MYC as therapeutic target for embryonal tumors: potential and challenges. Curr. Cancer Drug Targets 16, 2-21. doi: 10.2174/1568009615666150916092745
    • (2016) Curr. Cancer Drug Targets , vol.16 , pp. 2-21
    • Shalaby, T.1    Grotzer, M.A.2
  • 111
    • 85020463503 scopus 로고    scopus 로고
    • Abstract A49: Clinically efficacy of the BET bromodomain inhibitor TEN-010 in an open-label substudy with patients with documented NUT-midline carcinoma (NMC)
    • Shapiro, G. I., Dowlati, A., LoRusso, P. M., Eder, J. P., Anderson, A., Do, K. T., et al. (2015). Abstract A49: Clinically efficacy of the BET bromodomain inhibitor TEN-010 in an open-label substudy with patients with documented NUT-midline carcinoma (NMC). Mol. Cancer Ther. 14(12Suppl.2):A49. doi: 10.1158/1535-7163.TARG-15-A49
    • (2015) Mol. Cancer Ther , vol.14 , Issue.12
    • Shapiro, G.I.1    Dowlati, A.2    LoRusso, P.M.3    Eder, J.P.4    Anderson, A.5    Do, K.T.6
  • 112
    • 84982731599 scopus 로고    scopus 로고
    • Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC-and TGF-beta-dependent mechanisms
    • Shi, X., Mihaylova, V. T., Kuruvilla, L., Chen, F., Viviano, S., Baldassarre, M., et al. (2016). Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC-and TGF-beta-dependent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 113, E4558-E4566. doi: 10.1073/pnas.1608319113
    • (2016) Proc. Natl. Acad. Sci. U.S.A , vol.113 , pp. E4558-E4566
    • Shi, X.1    Mihaylova, V.T.2    Kuruvilla, L.3    Chen, F.4    Viviano, S.5    Baldassarre, M.6
  • 113
    • 0032539534 scopus 로고    scopus 로고
    • A unique glucose-dependent apoptotic pathway induced by c-Myc
    • Shim, H., Chun, Y. S., Lewis, B. C., and Dang, C. V. (1998). A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. U.S.A. 95, 1511-1516
    • (1998) Proc. Natl. Acad. Sci. U.S.A , vol.95 , pp. 1511-1516
    • Shim, H.1    Chun, Y.S.2    Lewis, B.C.3    Dang, C.V.4
  • 114
    • 84888106365 scopus 로고    scopus 로고
    • Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer
    • Shimamura, T., Chen, Z., Soucheray, M., Carretero, J., Kikuchi, E., Tchaicha, J. H., et al. (2013). Efficacy of BET bromodomain inhibition in Kras-mutant non-small cell lung cancer. Clin. Cancer Res. 19, 6183-6192. doi: 10.1158/1078-0432.CCR-12-3904
    • (2013) Clin. Cancer Res , vol.19 , pp. 6183-6192
    • Shimamura, T.1    Chen, Z.2    Soucheray, M.3    Carretero, J.4    Kikuchi, E.5    Tchaicha, J.H.6
  • 115
    • 0032030327 scopus 로고    scopus 로고
    • DNA tetraplex formation in the control region of c-myc
    • Simonsson, T., Pecinka, P., and Kubista, M. (1998). DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res. 26, 1167-1172
    • (1998) Nucleic Acids Res , vol.26 , pp. 1167-1172
    • Simonsson, T.1    Pecinka, P.2    Kubista, M.3
  • 116
    • 0025765770 scopus 로고
    • Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells
    • Sklar, M. D., Thompson, E., Welsh, M. J., Liebert, M., Harney, J., Grossman, H. B., et al. (1991). Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol. Cell. Biol. 11, 3699-3710. doi: 10.1128/MCB.11.7.3699
    • (1991) Mol. Cell. Biol , vol.11 , pp. 3699-3710
    • Sklar, M.D.1    Thompson, E.2    Welsh, M.J.3    Liebert, M.4    Harney, J.5    Grossman, H.B.6
  • 117
    • 84937693735 scopus 로고    scopus 로고
    • Ibrutinib in B lymphoid malignancies
    • Smith, M. R. (2015). Ibrutinib in B lymphoid malignancies. Expert Opin. Pharmacother. 16, 1879-1887. doi: 10.1517/14656566.2015.1067302
    • (2015) Expert Opin. Pharmacother , vol.16 , pp. 1879-1887
    • Smith, M.R.1
  • 119
    • 84942113043 scopus 로고    scopus 로고
    • Small molecule MYC inhibitor conjugated to integrin-targeted nanoparticles extends survival in a mouse model of disseminated multiple myeloma
    • Soodgupta, D., Pan, D., Cui, G., Senpan, A., Yang, X., Lu, L., et al. (2015). Small molecule MYC inhibitor conjugated to integrin-targeted nanoparticles extends survival in a mouse model of disseminated multiple myeloma. Mol. Cancer Ther. 14, 1286-1294. doi: 10.1158/1535-7163.MCT-14-0774-T
    • (2015) Mol. Cancer Ther , vol.14 , pp. 1286-1294
    • Soodgupta, D.1    Pan, D.2    Cui, G.3    Senpan, A.4    Yang, X.5    Lu, L.6
  • 120
    • 81355164530 scopus 로고    scopus 로고
    • Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinoma
    • Soucek, L., Buggy, J. J., Kortlever, R., Adimoolam, S., Monclus, H. A., Allende, M. T., et al. (2011). Modeling pharmacological inhibition of mast cell degranulation as a therapy for insulinoma. Neoplasia 13, 1093-1100. doi: 10.1593/neo.11980
    • (2011) Neoplasia , vol.13 , pp. 1093-1100
    • Soucek, L.1    Buggy, J.J.2    Kortlever, R.3    Adimoolam, S.4    Monclus, H.A.5    Allende, M.T.6
  • 121
    • 0036594548 scopus 로고    scopus 로고
    • Myc-Is this the oncogene from Hell?
    • Soucek, L., and Evan, G. (2002). Myc-Is this the oncogene from Hell? Cancer Cell 1, 406-408. doi: 10.1016/S1535-6108(02)00077-6
    • (2002) Cancer Cell , vol.1 , pp. 406-408
    • Soucek, L.1    Evan, G.2
  • 122
    • 0032511987 scopus 로고    scopus 로고
    • Design and properties of a Myc derivative that efficiently homodimerizes
    • Soucek, L., Helmer-Citterich, M., Sacco, A., Jucker, R., Cesareni, G., and Nasi, S. (1998). Design and properties of a Myc derivative that efficiently homodimerizes. Oncogene 17, 2463-2472. doi: 10.1038/sj.onc.1202199
    • (1998) Oncogene , vol.17 , pp. 2463-2472
    • Soucek, L.1    Helmer-Citterich, M.2    Sacco, A.3    Jucker, R.4    Cesareni, G.5    Nasi, S.6
  • 123
    • 0037096903 scopus 로고    scopus 로고
    • Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis
    • Soucek, L., Jucker, R., Panacchia, L., Ricordy, R., Tato, F., and Nasi, S. (2002). Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. Cancer Res. 62, 3507-3510
    • (2002) Cancer Res , vol.62 , pp. 3507-3510
    • Soucek, L.1    Jucker, R.2    Panacchia, L.3    Ricordy, R.4    Tato, F.5    Nasi, S.6
  • 124
    • 34948852371 scopus 로고    scopus 로고
    • Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors
    • Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., and Evan, G. I. (2007). Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat. Med. 13, 1211-1218. doi: 10.1038/nm1649
    • (2007) Nat. Med , vol.13 , pp. 1211-1218
    • Soucek, L.1    Lawlor, E.R.2    Soto, D.3    Shchors, K.4    Swigart, L.B.5    Evan, G.I.6
  • 125
    • 4544221109 scopus 로고    scopus 로고
    • Omomyc expression in skin prevents Myc-induced papillomatosis
    • Soucek, L., Nasi, S., and Evan, G. I. (2004). Omomyc expression in skin prevents Myc-induced papillomatosis. Cell Death Differ. 11, 1038-1045. doi: 10.1038/sj.cdd.4401443
    • (2004) Cell Death Differ , vol.11 , pp. 1038-1045
    • Soucek, L.1    Nasi, S.2    Evan, G.I.3
  • 127
    • 84874835799 scopus 로고    scopus 로고
    • Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice
    • Soucek, L., Whitfield, J. R., Sodir, N. M., Massó-Vallés, D., Serrano, E., Karnezis, A. N., et al. (2013). Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. Genes Dev. 27, 504-513. doi: 10.1101/gad.205542.112
    • (2013) Genes Dev , vol.27 , pp. 504-513
    • Soucek, L.1    Whitfield, J.R.2    Sodir, N.M.3    Massó-Vallés, D.4    Serrano, E.5    Karnezis, A.N.6
  • 129
    • 85011653974 scopus 로고    scopus 로고
    • Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers
    • Sun, K., Atoyan, R., Borek, M. A., DellaRocca, S., Samson, M. E., Ma, A. W., et al. (2016). Dual HDAC and PI3K inhibitor CUDC-907 downregulates MYC and suppresses growth of MYC-dependent cancers. Mol. Cancer Ther. 16, 285-299. doi: 10.1158/1535-7163.MCT-16-0390
    • (2016) Mol. Cancer Ther , vol.16 , pp. 285-299
    • Sun, K.1    Atoyan, R.2    Borek, M.A.3    DellaRocca, S.4    Samson, M.E.5    Ma, A.W.6
  • 130
    • 84964057646 scopus 로고    scopus 로고
    • Deubiquitinating c-Myc: USP36 steps up in the nucleolus
    • Sun, X. X., Sears, R. C., and Dai, M. S. (2015). Deubiquitinating c-Myc: USP36 steps up in the nucleolus. Cell Cycle 14, 3786-3793. doi: 10.1080/15384101.2015.1093713
    • (2015) Cell Cycle , vol.14 , pp. 3786-3793
    • Sun, X.X.1    Sears, R.C.2    Dai, M.S.3
  • 132
    • 84945573978 scopus 로고    scopus 로고
    • Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering RNA (DsiRNA) targeting MYC, in a phase I study in patients with advanced solid tumors
    • Tolcher, A. W., Papadopoulos, K. P., Patnaik, A., Rasco, D. W., Martinez, D., Wood, D. L., et al. (2015). Safety and activity of DCR-MYC, a first-in-class Dicer-substrate small interfering RNA (DsiRNA) targeting MYC, in a phase I study in patients with advanced solid tumors. J. Clin. Oncol. 33(Suppl; abstr 11006)
    • (2015) J. Clin. Oncol , vol.33
    • Tolcher, A.W.1    Papadopoulos, K.P.2    Patnaik, A.3    Rasco, D.W.4    Martinez, D.5    Wood, D.L.6
  • 134
    • 84880799558 scopus 로고    scopus 로고
    • Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5
    • Wang, H., Chauhan, J., Hu, A., Pendleton, K., Yap, J. L., Sabato, P. E., et al. (2013). Disruption of Myc-Max heterodimerization with improved cell-penetrating analogs of the small molecule 10074-G5. Oncotarget 4, 936-947. doi: 10.18632/oncotarget.1108
    • (2013) Oncotarget , vol.4 , pp. 936-947
    • Wang, H.1    Chauhan, J.2    Hu, A.3    Pendleton, K.4    Yap, J.L.5    Sabato, P.E.6
  • 136
    • 41149113439 scopus 로고    scopus 로고
    • c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle
    • Wang, H., Mannava, S., Grachtchouk, V., Zhuang, D., Soengas, M. S., Gudkov, A. V., et al. (2008). c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27, 1905-1915. doi: 10.1038/sj.onc.1210823
    • (2008) Oncogene , vol.27 , pp. 1905-1915
    • Wang, H.1    Mannava, S.2    Grachtchouk, V.3    Zhuang, D.4    Soengas, M.S.5    Gudkov, A.V.6
  • 137
    • 84946043971 scopus 로고    scopus 로고
    • A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors
    • Wang, H., Ramakrishnan, A., Fletcher, S., and Prochownik, E. V. (2015a). A quantitative, surface plasmon resonance-based approach to evaluating DNA binding by the c-Myc oncoprotein and its disruption by small molecule inhibitors. J. Biol. Methods 2:e18. doi: 10.14440/jbm.2015.54
    • (2015) J. Biol. Methods , vol.2
    • Wang, H.1    Ramakrishnan, A.2    Fletcher, S.3    Prochownik, E.V.4
  • 138
    • 84946070842 scopus 로고    scopus 로고
    • Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
    • Wang, H., Teriete, P., Hu, A., Raveendra-Panickar, D., Pendelton, K., Lazo, J. S., et al. (2015b). Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids. Oncotarget 6, 32380-32395. doi: 10.18632/oncotarget.6116
    • (2015) Oncotarget , vol.6 , pp. 32380-32395
    • Wang, H.1    Teriete, P.2    Hu, A.3    Raveendra-Panickar, D.4    Pendelton, K.5    Lazo, J.S.6
  • 139
    • 2342495721 scopus 로고    scopus 로고
    • Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway
    • Wang, Y., Engels, I. H., Knee, D. A., Nasoff, M., Deveraux, Q. L., and Quon, K. C. (2004). Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell 5, 501-512. doi: 10.1016/S1535-6108(04)00113-8
    • (2004) Cancer Cell , vol.5 , pp. 501-512
    • Wang, Y.1    Engels, I.H.2    Knee, D.A.3    Nasoff, M.4    Deveraux, Q.L.5    Quon, K.C.6
  • 140
    • 84943784340 scopus 로고    scopus 로고
    • CDK7-dependent transcriptional addiction in triple-negative breast cancer
    • Wang, Y., Zhang, T., Kwiatkowski, N., Abraham, B. J., Lee, T. I., Xie, S., et al. (2015c). CDK7-dependent transcriptional addiction in triple-negative breast cancer. Cell 163, 174-186. doi: 10.1016/j.cell.2015.08.063
    • (2015) Cell , vol.163 , pp. 174-186
    • Wang, Y.1    Zhang, T.2    Kwiatkowski, N.3    Abraham, B.J.4    Lee, T.I.5    Xie, S.6
  • 141
    • 0034958529 scopus 로고    scopus 로고
    • Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys
    • Webb, M. S., Tortora, N., Cremese, M., Kozlowska, H., Blaquiere, M., Devine, D. V., et al. (2004). Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys. Antisense Nucleic Acid Drug Dev. 11, 155-163. doi: 10.1089/108729001300338681
    • (2004) Antisense Nucleic Acid Drug Dev , vol.11 , pp. 155-163
    • Webb, M.S.1    Tortora, N.2    Cremese, M.3    Kozlowska, H.4    Blaquiere, M.5    Devine, D.V.6
  • 142
    • 41549090369 scopus 로고    scopus 로고
    • Multiple pathways regulated by the tumor suppressor PP2A in transformation
    • Westermarck, J., and Hahn, W. C. (2008). Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol. Med. 14, 152-160. doi: 10.1016/j.molmed.2008.02.001
    • (2008) Trends Mol. Med , vol.14 , pp. 152-160
    • Westermarck, J.1    Hahn, W.C.2
  • 143
    • 84857648310 scopus 로고    scopus 로고
    • Tumor microenvironment: becoming sick of Myc
    • Whitfield, J. R., and Soucek, L. (2012). Tumor microenvironment: becoming sick of Myc. Cell. Mol. Life Sci. 69, 931-934. doi: 10.1007/s00018-011-0860-x
    • (2012) Cell. Mol. Life Sci , vol.69 , pp. 931-934
    • Whitfield, J.R.1    Soucek, L.2
  • 144
    • 84979837852 scopus 로고    scopus 로고
    • Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal cancer
    • Wiegering, A., Uthe, F. W., Jamieson, T., Ruoss, Y., Huttenrauch, M., Kuspert, M., et al. (2015). Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal cancer. Cancer Discov. 5, 768-781. doi: 10.1158/2159-8290.CD-14-1040
    • (2015) Cancer Discov , vol.5 , pp. 768-781
    • Wiegering, A.1    Uthe, F.W.2    Jamieson, T.3    Ruoss, Y.4    Huttenrauch, M.5    Kuspert, M.6
  • 145
    • 73349096880 scopus 로고    scopus 로고
    • Stabilization of G-quadruplex DNA with platinum(II) Schiffbase complexes: luminescent probe and down-regulation of c-myc oncogene expression
    • Wu, P., Ma, D. L., Leung, C. H., Yan, S. C., Zhu, N., Abagyan, R., et al. (2009). Stabilization of G-quadruplex DNA with platinum(II) Schiffbase complexes: luminescent probe and down-regulation of c-myc oncogene expression. Chemistry 15, 13008-13021. doi: 10.1002/chem.200901943
    • (2009) Chemistry , vol.15 , pp. 13008-13021
    • Wu, P.1    Ma, D.L.2    Leung, C.H.3    Yan, S.C.4    Zhu, N.5    Abagyan, R.6
  • 146
    • 33644762865 scopus 로고    scopus 로고
    • A credit-card library approach for disrupting protein-protein interactions
    • Xu, Y., Shi, J., Yamamoto, N., Moss, J. A., Vogt, P. K., and Janda, K. D. (2006). A credit-card library approach for disrupting protein-protein interactions. Bioorg. Med. Chem. 14, 2660-2673. doi: 10.1016/j.bmc.2005.11.052
    • (2006) Bioorg. Med. Chem , vol.14 , pp. 2660-2673
    • Xu, Y.1    Shi, J.2    Yamamoto, N.3    Moss, J.A.4    Vogt, P.K.5    Janda, K.D.6
  • 147
    • 77956369534 scopus 로고    scopus 로고
    • Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase
    • Yang, D., Liu, H., Goga, A., Kim, S., Yuneva, M., and Bishop, J. M. (2010). Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase. Proc. Natl. Acad. Sci. U.S.A. 107, 13836-13841. doi: 10.1073/pnas.1008366107
    • (2010) Proc. Natl. Acad. Sci. U.S.A , vol.107 , pp. 13836-13841
    • Yang, D.1    Liu, H.2    Goga, A.3    Kim, S.4    Yuneva, M.5    Bishop, J.M.6
  • 148
    • 84946606473 scopus 로고    scopus 로고
    • The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition
    • Yao, W., Yue, P., Khuri, F. R., and Sun, S. Y. (2015). The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition. Oncotarget 6, 34669-34679. doi: 10.18632/oncotarget.5785
    • (2015) Oncotarget , vol.6 , pp. 34669-34679
    • Yao, W.1    Yue, P.2    Khuri, F.R.3    Sun, S.Y.4
  • 149
  • 150
    • 0142057146 scopus 로고    scopus 로고
    • Low molecular weight inhibitors of Myc-Max interaction and function
    • Yin, X., Giap, C., Lazo, J. S., and Prochownik, E. V. (2003). Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene 22, 6151-6159. doi: 10.1038/sj.onc.1206641
    • (2003) Oncogene , vol.22 , pp. 6151-6159
    • Yin, X.1    Giap, C.2    Lazo, J.S.3    Prochownik, E.V.4
  • 151
    • 84960153293 scopus 로고    scopus 로고
    • Structure-based inhibitor design for the intrinsically disordered protein c-myc
    • Yu, C., Niu, X., Jin, F., Liu, Z., Jin, C., and Lai, L. (2016). Structure-based inhibitor design for the intrinsically disordered protein c-myc. Sci. Rep. 6:22298. doi: 10.1038/srep22298
    • (2016) Sci. Rep , vol.6 , pp. 22298
    • Yu, C.1    Niu, X.2    Jin, F.3    Liu, Z.4    Jin, C.5    Lai, L.6
  • 152
    • 34347402459 scopus 로고    scopus 로고
    • Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
    • Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., and Lazebnik, Y. (2007). Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 178, 93-105. doi: 10.1083/jcb.200703099
    • (2007) J. Cell Biol , vol.178 , pp. 93-105
    • Yuneva, M.1    Zamboni, N.2    Oefner, P.3    Sachidanandam, R.4    Lazebnik, Y.5
  • 153
    • 84881670536 scopus 로고    scopus 로고
    • Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy
    • Zhang, Y., Peng, L., Mumper, R. J., and Huang, L. (2013). Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy. Biomaterials 34, 8459-8468. doi: 10.1016/j.biomaterials.2013.07.050
    • (2013) Biomaterials , vol.34 , pp. 8459-8468
    • Zhang, Y.1    Peng, L.2    Mumper, R.J.3    Huang, L.4
  • 154
    • 84879454970 scopus 로고    scopus 로고
    • Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model
    • Zhu, Q., Feng, C., Liao, W., Zhang, Y., and Tang, S. (2013). Target delivery of MYCN siRNA by folate-nanoliposomes delivery system in a metastatic neuroblastoma model. Cancer Cell Int. 13:65. doi: 10.1186/1475-2867-13-65
    • (2013) Cancer Cell Int , vol.13 , pp. 65
    • Zhu, Q.1    Feng, C.2    Liao, W.3    Zhang, Y.4    Tang, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.